[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575800":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":34,"centralContacts":41,"locations":46,"responsibleParty":68,"collaborators":71,"id":75,"slug":26,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":80,"eligibilityCriteria":81,"healthyVolunteers":76,"sex":82,"minAge":83,"maxAge":84,"enrollmentInfo":85,"targetDuration":26,"studyType":88,"phases":89,"briefSummary":91,"conditions":92,"keywords":98,"overallStatus":48,"whyStopped":26,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":108,"completionDateStruct":110,"leadSponsor":112,"locationsCount":113},{"fullName":5,"class":6},"University of California, Los Angeles","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Positive Affect Treatment - Behavioral (PAT-B)","EXPERIMENTAL","Focused on improving reward processing and anhedonia using PAT-B. Expected to reduce negative affect and increase positive affect. Then, exposure therapy to reduce public speaking anxiety.",[13,14],"Behavioral: Positive Affect Treatment - Behavioral (PAT-B)","Behavioral: Exposure Therapy",{"label":16,"type":17,"description":18,"interventionNames":19},"Relaxation Treatment","ACTIVE_COMPARATOR","Focused on relaxation and mindfulness using Relaxation Treatment. Expected to reduce negative affect. Then, exposure therapy to reduce public speaking anxiety.",[20,14],"Behavioral: Relaxation Treatment",[22,27,30],{"type":23,"name":9,"description":24,"armGroupLabels":25,"otherNames":26},"BEHAVIORAL","8 therapy sessions conducted individually with a therapist. Focuses on improving reward processing to increase positive emotional experience. Specific techniques include psychoeducation on mood cycle and positive emotions, mood monitoring, behavioral activation, and imaginal recounting and savoring of behavioral activation events. Intervention includes between-session practice.",[9],null,{"type":23,"name":16,"description":28,"armGroupLabels":29,"otherNames":26},"8 therapy sessions conducted individually with a therapist. Focuses on mindfulness and relaxation skills. Specific techniques include mindfulness approaches from dialectical behavior therapy, diaphragmatic breathing, and progressive muscle relaxation. Intervention includes between-session practice.",[16],{"type":23,"name":31,"description":32,"armGroupLabels":33,"otherNames":26},"Exposure Therapy","8 therapy sessions conducted individually with a therapist using the inhibitory retrieval model of exposure therapy. Sessions are designed to include four exposures each (32 exposures total). Each exposure is a public speech delivered to an audience. Goal of this treatment is to reduce public speaking anxiety. Principles of exposure therapy that will be incorporated are maximizing prediction error, maintaining attention to the situation\u002Fstimuli that are perceived predictors of the feared outcome (e.g., social rejection), removing safety signals, variability, engaging in post-exposure rehearsal\u002Fconsolidation, deepened extinction, and positive occasion setter extinction. Intervention does not include between-session practice.",[9,16],[35,38],{"name":36,"affiliation":5,"role":37},"Tomislav D Zbozinek, PhD","PRINCIPAL_INVESTIGATOR",{"name":39,"affiliation":5,"role":40},"Michelle G Craske, PhD","STUDY_CHAIR",[42],{"name":36,"role":43,"phone":44,"phoneExt":26,"email":45},"CONTACT","6027502348","tzbozinek@ucla.edu",[47,61],{"facility":5,"status":48,"city":49,"state":50,"zip":51,"country":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"RECRUITING","Los Angeles","California","90024","United States",{"type":54,"coordinates":55},"Point",[56,57],-118.24368,34.05223,{"lat":57,"lon":56},[60],{"name":36,"role":43,"phone":44,"phoneExt":26,"email":45},{"facility":5,"status":48,"city":49,"state":50,"zip":51,"country":52,"cosmosGeoPoint":62,"geoPoint":64,"contacts":65},{"type":54,"coordinates":63},[56,57],{"lat":57,"lon":56},[66],{"name":36,"role":43,"phone":67,"phoneExt":26,"email":45},"310-206-9191",{"type":37,"investigatorFullName":69,"investigatorTitle":70,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Tomislav Zbozinek, PhD","Assistant Project Scientist",[72],{"name":73,"class":74},"National Institute of Mental Health (NIMH)","NIH","100575800",false,"NCT06776991","Reward Processing and Exposure Therapy for Social Anxiety Disorder","Reward Processing and Exposure Therapy","METER","Inclusion Criteria:\n\n* Diagnosis of social anxiety disorder from the Structural Clinical Interview for DSM 5.\n* Elevated fear of public speaking, defined as a score of \\>= 66 (+1SD from the mean of population norms on a scale of 17-85) on the Public Speaking Anxiety Scale (PSAS; Bartholomay, E. M., \\& Houlihan, D. D. (2016). Public Speaking Anxiety Scale: Preliminary psychometric data and scale validation. Personality and individual differences, 94, 211-215), which is a self-report scale measuring anxiety of public speaking.\n* Low reward processing, defined as a score of \\\u003C56 (less than the population mean) on the Dimensional Anhedonia Rating Scale (DARS) (Rizvi, S. J., Quilty, L. C., Sproule, B. A., Cyriac, A., Bagby, R. M., \\& Kennedy, S. H. (2015). Dimensional Anhedonia Rating Scale (DARS) \\[Database record\\]. APA PsycTests).\n* Medication-free or stabilized on psychotropic medications for a minimum standard length of time (1 month for benzodiazepines and beta blockers, 3 months for SRIs\u002FSNRIs and heterocyclics).\n* Psychotherapy-free or stabilized on alternative psychotherapies other than cognitive or behavioral therapies that were not focused on their anxiety disorder for at least 6 months prior to study entry.\n* Age 18-60.\n* Fluent in English.\n* To conduct MRI version of fear conditioning task, must have no MRI contraindications.\n\nExclusion Criteria (none of the following):\n\n* Recent suicidal ideation with intent or plan - defined as suicidal ideation with intent or plan in the past year.\n* Lifetime history of suicide attempts.\n* History of bipolar disorder, psychosis, intellectual disability, or organic brain damage.\n* Substance use disorder within the last 6 months.\n* Major respiratory, cardiovascular, pulmonary, neurological, or muscular-skeletal diseases.\n* Pregnant or planning to become pregnant for next 6 months.","ALL","18 Years","60 Years",{"count":86,"type":87},94,"ESTIMATED","INTERVENTIONAL",[90],"NA","The investigators are conducting a clinical trial of therapy for public speaking anxiety. There are many eligibility criteria, but the main ones are that participants need to be socially anxious and have public speaking anxiety. In this clinical trial, all participants will do exposure therapy. Before doing exposure therapy in the study, though, participants will be randomized to do one of two treatments: i) a positive mood treatment, which is designed to increase how positive people feel, and ii) a relaxation treatment, which is designed to help people feel more relaxed. The investigators are doing this study to see whether doing the positive mood treatment or relaxation treatment first will affect how well exposure therapy works.",[93,94,95,96,97],"Social Anxiety Disorder (Social Phobia)","Public Speaking Anxiety","Anhedonia","ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)","Phobic Disorders",[31,99,100,94,95,101,102,103,16],"Anxiety","Social Anxiety","Reward Processing","Inhibitory Retrieval","Positive Affect Treatment","2026-04-01",{"date":106,"type":107},"2026-04-02","ACTUAL",{"date":109,"type":107},"2024-09-26",{"date":111,"type":87},"2029-04-30",{"name":5,"class":6},2]